Products for Research Use Only

Lipopeptide CPE4 (TFA)

CAT: 0804-HY-P11455A-01Size: 100 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P11455A-01Size:100 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lipopeptide CPE4 TFA is a PEG-modified peptide E4 [ (EIAALEK) 4]. Lipopeptide CPE4 TFA is capable of coiled-coil formation when attached to liposomes. Lipopeptide CPE4 TFA triggers membrane fusion between liposomes and living cells with concomitant efficient cytosolic delivery of a variety of compounds such as fluorescent dyes Propidium Iodide (PI) and TO-PRO-3 iodide (HY-117070), and Doxorubicin (DOX) (HY-15142A). Lipopeptide CPE4 TFA can be used for drug delivery research[1].
UNSPSC
12352209
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Purity
98.69
Smiles
CC(C)CCC[C@H]([C@@](CC[C@]1([C@@]2(CC=C(C3)[C@@]4(CC[C@@H]3NC(CCC(NCCOCCOCCOCCOCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCN)=O)CCC(O)=O)=O)CC(C)C)=O)C)=O)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCCCN)=O)CCC(O)=O)=O)CC(C)C)=O)C)=O)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCCCN)=O)CCC(O)=O)=O)CC(C)C)=O)C)=O)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCCCN)=O)CCC(O)=O)=O)CC(C)C)=O)C)=O)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)=O)=O)C)[H])[H])([C@@](CC[C@@]24[H])1C)[H])C.OC(C(F)(F)F)=O.[x]
Molecular Formula
C177H303N35O51.xC2HF3O2
Molecular Weight
3737.50 (free base)
References & Citations
[1]Yang J, et al. Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS Cent Sci. 2016 Sep 28;2 (9) :621-630.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported